Diabetes Drug Avandia Linked to Increased Risk of Heart Attacks

Pete Strom

Attorney
(866) 735-1102 Ext 590

0 CommentsPrint ArticleSubscribe

Avandia, a drug prescribed for diabetes patients to control blood sugar levels, has been linked to an increased risk of heart attacks and heart-related deaths, studies show. The Federal Drug Administration released a safety alert in May, warning of the increased heart associated risks linked to Avandia.

According to the FDA's release, patients on Avandia who also take insulin, particularly those with previous heart conditions or disease, have an especially high risk for heart attacks or heart-related deaths.

On Monday, the FDA will meet with outside experts to discuss what actions should be taken in light of the associated risks. The FDA could decide to stop selling the drug or require more warning labels. Avandia is the world's best selling diabetes drug, with over 3 million users in America alone.

As an attorney with experience in defective drug lawsuits, my heart goes out to anyone who has already experienced side effects from using Avandia.

For more information on this subject, please refer to our section on Drugs, Medical Devices, and Implants.